PDA Honor Awards: Gordon Personeus and Frederick Carleton Awards

Each week, the PDA Letter will publish announcements for the winners of the 2019 Honor Awards. PDA thanks all of the recipients for their contributions to the Association.

Gordon Personeus Award

Presented in the memory of past PDA President and longtime volunteer, Gordon Personeus, this award honors a PDA member, other than a Board member, for long-term contributions of special importance to PDA. For 2019, PDA recognizes Cylia Chen-Ooi, Amgen, and Thomas Schoenknecht, PhD, Lonza.

Cylia has been involved in PDA’s quality metrics and quality culture initiatives. She is the co-leader of PDA Quality Metrics/Culture Task Force Team and has served on program planning committees for PDA’s quality metrics conferences in addition to her involvement on commenting teams for U.S. FDA guidance documents.

Thomas, who unfortunately passed away earlier this year, was also a longtime volunteer for PDA. Most recently, he was conference chair for the 2019 The Universe of Pre-filled Syringes and Injection Devices conference and exhibition. He was also a member of the Glass Task Force and served as the European leader of the Combination Products Interest Group.

Frederick Carleton Awards

Presented in tribute to lifetime contributor, past President, past Executive Director, and Honorary Member, Frederick J. Carleton, this award recognizes past or present Board members. PDA recognizes former board members Ursula Busse, PhD, Novartis, and Dr. -Ing. Stephan K. Roenninger, Amgen, for their contributions to PDA.

Ursula received the award in recognition of her service on the Board of Directors from 2012–201
8. She has been a member of the Paradigm Change in Manufacturing Operations^SM Task Force and the PDA Post Approval Change: Innovation for Availability of Medicines Task Force. She has also participated as a member of the planning committee for several Annual Meetings.

In addition to serving on the Board of Directors, Stephan has volunteered for numerous task forces and committees. He has also served on the Regulatory Affairs and Quality Advisory Board. Stephan has also served as a leader on PDA’s drug shortages initiatives as well as a resource for ICH guidelines.